Safety of phosphatidylserine containing omega-3 fatty acids in non-demented elderly: a double-blind placebo-controlled trial followed by an open-label extension

Table 7 Adverse events reported during the course of the open-label extension*

PS-DHA continuers		PS-DHA naive**
Adverse event	Number of related or probably related adverse events	Number of not-related or probably not related adverse events	Number of not-related or probably not related adverse events
Gastrointestinal discomfort	1		3
Hypertension		1	3
Hypotension		1
Fall		1
Tenesmus	1
Amaurosis fugax		1
Mild bleeding due to Hemorrhoids		1
Platelets decrease		1
Hand Fracture		1
Hyperlipidemia			1
Dizziness		1
Urinal tract infection			1
Arm pigmentation			1
Headache	1	1
SUM	3 events in 3 participants	9 events in 7 participants	9 events in 6 participants

* Judged by the study physicians as related, probably related, not related or probably not related to the study treatment
** There were no adverse events classified by the study physicians as related or probably related to the study treatment

ISSN: 1471-2377